Reaction
Granulomatous Dermatitis reporting signals
As of the last recalculation, Granulomatous Dermatitis appears in 237 FAERS reports alongside 3 co-occurring drug terms. The strongest observed disproportionality signal is VALGANCICLOVIR HYDROCHLORIDE POWDER, (PRR 99.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Valganciclovir Hydrochloride Powder, | 13 | 99.0 | 99.1 |
| Valganciclovir | 13 | 64.0 | 64.1 |
| Valganciclovir Hydrochloride | 13 | 64.0 | 64.1 |